Home » Topics » BioWorld Science

BioWorld Science
RSS

Seres Therapeutics discloses bacterial compositions

Nov. 12, 2019

Emergex Vaccines descibes new filovirus vaccines

Nov. 12, 2019

HOOKIPA Pharma presents phase I data for CMV vaccine HB-101

Nov. 12, 2019

ALBI as a promising prognostic marker in predicting survival from HCC

Nov. 12, 2019

MRX-1669, a novel small-molecule Myc inhibitor with promising in vitro activity

Nov. 12, 2019

SAR-20351 demonstrates promising safety and efficacy in syngeneic tumor models

Nov. 12, 2019

Turning Point Therapeutics initiates phase I/II trial of TPX-0046

Nov. 12, 2019

Topline phase II data presented for TNP-2092

Nov. 12, 2019

Indalo Therapeutics presents first clinical data for IDL-2965

Nov. 12, 2019

FDA clears IND application for ACH-5228

Nov. 12, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...